中文名称: | L-365260 | ||||
---|---|---|---|---|---|
英文名称: | L-365260 | ||||
别名: | N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea | ||||
CAS No: | 118101-09-0 | 分子式: | C24H22N4O2 | 分子量: | 398.46 |
CAS No: | 118101-09-0 | ||||
分子式: | C24H22N4O2 | ||||
分子量: | 398.46 |
基本信息
产品编号: |
L60016 |
||||
产品名称: |
L-365260 |
||||
CAS: |
118101-09-0 |
储存条件 |
粉末 |
-20℃ |
四年 |
分子式: |
溶于液体 |
-80℃ |
二年 |
||
分子量: |
398.46 |
|
|
||
化学名: |
N-[(3R)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-N'-(3-methylphenyl)urea |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
|
||||
Water |
|
||||
体内(现配现用): |
|
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
生物活性
产品描述 |
一种有效和选择性的非肽胃泌素和脑胆囊收缩素受体 (CCK-B) 拮抗剂。 |
|
靶点 |
Ki:1.9nM (gastrin);2.0nM (CCK-B) |
|
体外研究 |
L-365260 (1μM) strongly attenuates the CCK8S- and CCK4-mediated depolarization in a different neuron.L-365260 exhibits a similar high affinity for brain CCK-B receptors of rats, mice and man,and a lower affinity for gastrin and brain CCK-B (IC50=20-40nM) receptors in dog tissues. |
|
体内研究 |
L-365260 (0.01-10mg/kg;s.c.) enhances analgesia induced by a submaximal dose of Morphine (4mg/kg) in rats.L-365260 (0.2mg/kg;s.c.twice daily for 5 days) significantly prolongs the duration of Morphine analgesia in rats.L-365260 (0.1-30mg/kg;p.o.) antagonizes gastrin-stimulated acid secretion in mice (ED50=0.03mg/kg),rats (ED50=0.9mg/kg) and guinea pigs (ED50=5.1mg/kg). |
|
Animal Model: |
Male Sprague-Dawley rats (300-350g) were injected with Morphine. |
|
Dosage: |
0.01,0.05,0.1,0.2,0.75,1.0,10.0mg/kg |
|
Administration: |
S.c.10 min prior to i.p.injection of 4mg/kg Morphine |
|
Result: |
Enhanced morphine analgesia. |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )